Activist Elliott makes inroads at Catalent to build value. Here’s what could happen next
Rows of glass vials in a biologics laboratory in Sweden. Photographer: Mikael Sjoberg/BloombergBloomberg Creative | Bloomberg Creative Photos | Getty ...
Rows of glass vials in a biologics laboratory in Sweden. Photographer: Mikael Sjoberg/BloombergBloomberg Creative | Bloomberg Creative Photos | Getty ...
© Reuters. A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium ...
Nastassia Samal Life sciences company Danaher Corporation (NYSE:DHR) has expressed interest in acquiring the contract manufacturer Catalent (NYSE:CTLT), Bloomberg reported ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.